Nurse Practitioner / Physician Assistant Spravato Treatment Clinician - Multiple Teams
No salary listed
Mid
New York, NY, USA
In PersonOn-site work at Long Island City; Brooklyn as needed.
Medical, Clinical & VeterinaryAdvanced Practice Providers
About the job
Requirements
- An active Nurse Practitioner or Physician Assistant license in the state of practice is required.
- Current, unrestricted Drug Enforcement Administration registration is required.
- Training or demonstrated ability to independently conduct comprehensive psychiatric intake evaluations, assess patient needs and clinical appropriateness for treatment, and make sound clinical decisions within the scope of licensure is required.
- Willingness to register or associate the Drug Enforcement Administration registration to partner site addresses as needed for Spravato operations is required.
- Comfort with outpatient monitoring and responding to clinical changes, including blood pressure changes, anxiety, and dissociation, is required.
- Strong documentation skills and reliability with protocols are required.
- Willingness to complete required Spravato REMS-related program training is required.
Responsibilities
- Conduct psychiatric intake evaluations and screening to determine Spravato eligibility.
- Prescribe Spravato and initiate documentation for insurance prior authorization.
- Provide on-site clinical support during Spravato dosing sessions; patients self-administer the nasal spray.
- Monitor patients during the observation period, including vital signs, safety checks, and symptom monitoring.
- Complete required documentation accurately and on time.
- Coordinate with Journey Clinical operations and partner sites to ensure smooth patient flow.
- Support a calm, safe environment for small cohorts, typically three to four patients per session block.
Desired Qualifications
- Psychiatry experience is preferred; experience with ketamine or esketamine, transcranial magnetic stimulation, infusion, or other monitoring workflows is ideal.
About the company
Journey Clinical offers Ketamine-Assisted Psychotherapy (KAP) for depression, anxiety, and PTSD. It acts as a one-stop treatment partner where a medical consultation leads to ketamine prescription, administration, and accompanying psychotherapy in a coordinated care plan. The approach blends ketamine's effects with structured psychotherapy to tackle symptoms from multiple angles under medical oversight. The company stands out with a patient-centered, collaborative care model and a team of MDs, PhDs, and licensed clinicians delivering personalized, accessible therapy.
Company Size
51-200
Company Stage
Series A
Total Funding
$11.5M
Headquarters
New York City, null
Founded
2020
Get referred to Journey Clinical
See people who can refer or advise you
Simplify's Take
What believers are saying
- DEA telemedicine flexibilities stay open through December 31, 2026, supporting remote ketamine prescribing.
- Journey Clinical says major insurers cover KAP, and patients receive reimbursement in 30 states.
- The 2026 White House executive order boosts psychedelic medicine attention and future access pathways.
What critics are saying
- DEA telemedicine relief expires December 31, 2026; tighter rules would break its remote workflow.
- Georgia's 2026 ketamine-clinic law signals state licensing, ownership, and staffing scrutiny spreading nationwide.
- FDA ketamine safety warnings and compounding crackdowns threaten prescriber confidence, referrals, and Journey Clinical's existential market.
What makes Journey Clinical unique
- Journey Clinical runs therapist-led KAP with in-network prescribers across 30 states.
- It claims the largest U.S. psychedelic-assisted psychotherapy provider network, anchored by thousands of therapists.
- Its model keeps therapists independent while Journey Clinical handles medical oversight and prescribing.
Help us improve and share your feedback! Did you find this helpful?
Benefits
- Flexible Work Hours
- Remote Work Options
- Training Programs
- Hybrid Work Options